
Trxade Group MEDS
Quarterly report 2025-Q3
added 11-12-2025
Trxade Group Interest Expense 2011-2025 | MEDS
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Trxade Group
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.2 M | 336 K | 23.6 K | 29.4 K | 53.2 K | 57.5 K | 157 K | 152 K | 120 K | 4.15 K | 7.28 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.2 M | 4.15 K | 194 K |
Quarterly Interest Expense Trxade Group
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 252 K | 181 K | 62.4 K | - | 130 K | 9.16 K | 1.36 K | - | 5.62 K | 8.69 K | 7.26 K | - | 7.43 K | 7.31 K | 7.92 K | - | 13.4 K | 15.9 K | 17.6 K | - | 12.6 K | 10.9 K | 16.5 K | - | 30.9 K | 44.1 K | 61.7 K | - | 50.3 K | 29.8 K | 40.9 K | - | 47.2 K | 27.9 K | 969 | - | 2.06 K | 991 | 1.06 K | - | 851 | 563 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 252 K | 563 | 34.6 K |
Interest Expense of other stocks in the Pharmaceutical retailers industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Greenlane Holdings
GNLN
|
2.45 M | $ 2.99 | -3.24 % | $ 22.5 M | ||
|
BOQI International Medical
BIMI
|
170 K | - | 6.33 % | $ 5.86 M | ||
|
PetMed Express
PETS
|
758 K | $ 3.02 | 70.69 % | $ 62.2 M | ||
|
LifeMD
LFMD
|
2.6 M | $ 3.45 | -4.43 % | $ 117 M | ||
|
Rite Aid Corporation
RAD
|
224 M | - | - | $ 35.5 M | ||
|
111
YI
|
-595 K | $ 3.7 | -4.15 % | $ 636 M | ||
|
Walgreens Boots Alliance
WBA
|
482 M | - | - | $ 10.3 B |